Log In
Print
BCIQ
Print
Print this Print this
 

RNAi therapeutic targeting transthyretin (TTR)

  Manage Alerts
Collapse Summary General Information
Company Arcturus Therapeutics Inc.
DescriptionRNAi therapeutic targeting the transthyretin (TTR) gene delivered using LUNAR technology
Molecular Target Transthyretin (TTR)
Mechanism of ActionGene silencing
Therapeutic ModalityNucleic acid: Linear RNA: siRNA
Latest Stage of DevelopmentPreclinical
Standard IndicationAmyloidosis
Indication DetailsTreat transthyretin (TTR)-mediated amyloidosis
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today